| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
RadNet, Inc. Common Stock$63.78
+1.09 (+1.74%)
Market Cap
4.30 B
EPS
-0.25
P/E Ratio
-219.96 $
Value Trade
33.27 M
SEC Financials
Q1 2026Dilution Risk
Revenue
575.63 M
Operating CF
78.97 M
Total Assets
3.89 B
Total Liabilities
2.53 B
Equity
1.08 B
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
455.34 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 11, 2026
Overview
Volume
596.17 K
52 Week Range
46.76 - 85.84
% held by Insiders
10.52 %
% held by Institutions
99.71 %
Enterprise Value
5.66 B
Total Shares
78.63 M
Short %
14.34 %
Float Shares
69.98 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in RDNT
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
RDNT Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-RDNT
Jul 22, 2026RadNet, Inc. Announces Date of its Second Quarter 2026 Financial Results Conference Call
RadNet, Inc. has announced a conference call scheduled for August 10, 2026, to discuss its second quarter financial results for the year. The call will be accessible to investors via phone and webcasts. RadNet is recognized as a leading provider of diagnostic imaging services across the United States.
Read more →-RDNT
Jun 10, 2026RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
RadNet, Inc. has secured a $250 million incremental term loan to support its growth initiatives. The loan, part of an amendment to its existing credit agreement, will mature in 2031 and is expected to finance acquisitions and expansions. Additionally, RadNet has successfully reduced the interest rates on its credit facilities by 0.25%, enhancing its financial position.
Read more →-RDNT
Jun 3, 2026RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
RadNet, Inc. announced plans to secure a $200 million incremental term loan to support its strategic growth initiatives. The funds will be used for acquisitions, organic expansion, and partnerships. The loan is expected to mature in April 2031, coinciding with the existing term loan. The company aims to finalize the transaction by mid-June 2026, pending market conditions.
Read more →-RDNT
May 28, 2026RadNet to Host Men's Health Webinar on June 13, 2026
RadNet, Inc. will host a free webinar on June 13, 2026, focusing on men's health issues, including coronary artery disease, prostate cancer, and lung cancer. The event will feature expert presentations and a live Q&A session, aiming to educate attendees on risk factors and the importance of early detection. This initiative aligns with National Men's Health Month, emphasizing preventive care.
Read more →-RDNT
May 11, 2026RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow Total Company Revenue increase
RadNet reported strong financial results for the first quarter of 2026, with total revenue of $575.6 million, a 22.1% increase from the previous year. Adjusted EBITDA also saw a significant rise of 36.3% to $63.3 million. The Digital Health segment performed well, increasing revenue by 51.5%. Despite facing some initial challenges from severe winter weather, the company has revised its guidance for the rest of the year upwards, reflecting positive trends in imaging volumes and operations.
Read more →-RDNT
May 10, 2026RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
RadNet, Inc. reported a record first quarter for 2026, with total revenue increasing by 22.1% to $575.6 million compared to the previous year. The company also saw a 36.3% rise in Adjusted EBITDA, driven by growth in advanced imaging procedures. Despite some challenges, including a decrease in Digital Health Adjusted EBITDA, RadNet has revised its financial guidance for the year upwards, reflecting strong operational trends.
Read more →-RDNT
Apr 28, 2026RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call
RadNet, Inc. has announced a conference call scheduled for May 11, 2026, to discuss its first quarter financial results. The call will be accessible to investors via phone and webcasts, ensuring broad participation. RadNet is recognized as a leading provider of diagnostic imaging services in the U.S., with a significant operational footprint.
Read more →-RDNT
Mar 4, 2026DeepHealth Unveils Industry’s Most Comprehensive Portfolio of Native Clinical AI Solutions at ECR 2026
DeepHealth has launched an extensive portfolio of AI solutions for clinical imaging at ECR 2026, enhancing capabilities across various modalities including MR, CT, and X-ray. The acquisition of Gleamer strengthens its position in routine imaging and diagnostic care. The new tools are designed to improve patient outcomes and operational efficiency in healthcare systems.
Read more →-RDNT
Mar 4, 2026RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS
RadNet, Inc. is hosting a conference call on March 5, 2026, to discuss its recent acquisition of Gleamer SAS and its Digital Health strategy. Investors will have the chance to hear from executive management and ask questions. RadNet continues to strengthen its position in the diagnostic imaging market with innovative AI solutions.
Read more →-RDNT
Mar 2, 2026▲ +7.7%on this newsshared move
RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance
RadNet reported a record revenue of $547.7 million for Q4 2025, marking a 14.8% increase from the previous year. Adjusted EBITDA also reached a record high of $87.7 million, reflecting a 16.9% growth. The company anticipates strong growth in 2026, particularly in its Digital Health segment, with revenue expected to rise by 46%-56%. However, RadNet faced a net loss of $0.6 million in Q4 2025, contrasting with a net income in the same quarter of 2024.
Read more →-RDNT
Mar 2, 2026▲ +7.7%on this newsshared move
RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
RadNet has acquired Gleamer, a leading radiology AI company, enhancing DeepHealth's position as the largest provider of clinical AI solutions globally. The acquisition aims to improve patient care and operational efficiencies through advanced AI technologies. Gleamer's impressive growth and portfolio will significantly augment DeepHealth's capabilities across various imaging modalities. The integration is expected to be completed by the third quarter of 2026.
Read more →-RDNT
Mar 2, 2026▲ +7.7%on this newsshared move
RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA (1) and Releases 2026 Financial Guidance Total Company Revenue increased 14.8% to a quarterly record of $547.
RadNet, Inc. reported record financial results for the fourth quarter of 2025, with total revenue of $547.7 million and an adjusted EBITDA of $87.7 million, marking significant year-over-year growth. The company attributed this success to increased demand for its imaging services and ongoing operational efficiencies. Despite this positive performance, RadNet experienced an unadjusted net loss of $0.6 million in Q4 and reported a net loss of $18.7 million for the full year. Looking ahead, the company aims to leverage its expanded Digital Health capabilities following the recent acquisition of Gleamer.
Read more →-RDNT
Feb 17, 2026RadNet, Inc. Announces Date of its Fourth Quarter 2025 Financial Results Conference Call
RadNet, Inc. has announced a conference call scheduled for March 2, 2026, to discuss its fourth quarter 2025 financial results. The call will take place at 7:30 a.m. Pacific Time and will be accessible to investors via phone and webcast. The company is recognized for its significant presence in the diagnostic imaging sector across multiple states.
Read more →-RDNT
Feb 3, 2026RadNet Enters Indiana with Acquisition of Northwest Radiology
RadNet, Inc. has acquired the outpatient imaging assets of Northwest Radiology Network, marking its entry into Indiana. The acquisition includes six multimodality outpatient centers in the greater Indianapolis area. This move is expected to enhance RadNet's operational scale and improve healthcare delivery through advanced technologies. The acquisition is projected to generate an additional $18 million in annual revenue.
Read more →-RDNT
Jan 9, 2026RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026
RadNet, Inc. announced that its executives will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The presentation will feature key leaders including Dr. Howard Berger and Mark Stolper, showcasing the company's advancements in diagnostic imaging. A live webcast will be available for those interested in the event.
Read more →-RDNT
Jan 7, 2026RadNet Names Four Leaders to Expanded Executive Roles Bench of veteran leaders elevated to drive RadNet's continued growth and innovation
RadNet, Inc. has promoted four senior leaders to expanded executive roles to capitalize on their operational excellence and drive further strategic growth. Key appointments include Stephen Forthuber and Norman Hames as Presidents and CEOs of their respective Eastern and Western Operations, along with Mital Patel as Executive VP and COO, and Dr. Greg Sorensen as Chief Strategy Officer. This leadership transition aims to maintain RadNet's strong growth trajectory and focus on delivering high-quality, patient-centered care amid its expansion in diagnostic imaging services.
Read more →-RDNT
Dec 1, 2025DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow
DeepHealth has launched the Breast Suite, an AI-powered suite of applications designed to enhance breast cancer detection and streamline workflows. This innovative technology aims to improve diagnostic accuracy and patient care by integrating advanced risk assessment tools and cloud-based solutions. Clinical studies have shown that the Breast Suite significantly increases detection rates, particularly among diverse and high-risk populations.
Read more →-RDNT
Nov 30, 2025DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
DeepHealth, a subsidiary of RadNet, unveiled its next-generation imaging informatics and clinical AI solutions at RSNA 2025. The expanded portfolio aims to enhance disease detection, patient engagement, and operational efficiency in healthcare. Key innovations include the DeepHealth OS, which integrates clinical and operational data, facilitating better healthcare delivery. The company showcases its advancements through interactive sessions at the conference.
Read more →-RDNT
Nov 10, 2025RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA (1) and Revises Upwards 2025 Financial Guidance Ranges Total Company Revenue increased 13.4% to $522.
RadNet, Inc. has reported a strong financial performance for the third quarter of 2025, with total revenues rising 13.4% to $522.9 million compared to the previous year. Adjusted EBITDA also saw a significant increase of 15.2%, reaching $84.9 million. The company experienced a notable growth in its Digital Health segment, with revenues surging 51.6%. Given the positive financial trends, RadNet has revised its full-year guidance upwards for both its Imaging Center and Digital Health segments.
Read more →-RDNT
Aug 11, 2025▲ +16.2%on this news· ran to +29% by day 3
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA (1) and Revises Upwards 2025 Financial Guidance Ranges Total Company Revenue increased 8.4% to a qua
RadNet, Inc. reported robust second quarter financial results for 2025, achieving record revenues of $498.2 million and Adjusted EBITDA of $81.2 million, reflecting significant growth from the previous year. Their Digital Health segment also performed strongly, with revenue increasing by 30.9%. Consequently, RadNet has revised its full-year 2025 financial guidance upwards based on these positive trends. The company's focus on enhancing advanced imaging capabilities and technology adoption is expected to sustain further growth, despite some one-time costs appearing in the financial data.
Read more →-RDNT
Jul 17, 2025RadNet's Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD Acquisition contributes iCAD's commercial, technology, and regulatory capabilities The acquisition positions DeepHealth with an industry-leading
RadNet's subsidiary, DeepHealth, has completed the acquisition of iCAD, enhancing its offerings in AI-powered breast cancer solutions. This acquisition is expected to bolster DeepHealth's commercial, technological, and regulatory capabilities, facilitating growth in cancer screening and diagnostics. The integration aims to improve breast cancer detection rates and workflow efficiency while expanding access across over 1,500 healthcare locations globally. Although the acquisition presents significant opportunities, it also contains risks related to integration and operational challenges.
Read more →-RDNT
Jun 11, 2025RadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate Initiatives
RadNet, a provider of diagnostic imaging services, has secured a $100 million incremental term loan from Barclays Bank. The loan will be used to finance future acquisitions and support general corporate initiatives, enhancing RadNet's capacity for growth. With this additional financing, RadNet intends to optimize its strategic objectives while maintaining a conservative capital structure. The maturity date of the loan aligns with existing credit agreements, demonstrating careful financial planning.
Read more →-RDNT
May 12, 2025RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA (1) First quarter Revenue was negatively impacted by approximately $
RadNet, Inc. reported its financial results for the first quarter of 2025, revealing a total revenue increase of 9.2% year-over-year, despite substantial challenges from Southern California wildfires and adverse weather conditions. The company faced a decline in Adjusted EBITDA of 20.6% and reported a net loss of $37.9 million. However, RadNet announced an acquisition agreement with iCAD to enhance its AI capabilities in breast cancer detection. Additionally, the company has revised its 2025 financial guidance upwards for revenue and Adjusted EBITDA.
Read more →-RDNT
Apr 16, 2025RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer The acquisition will unite complementary leading AI-powered cancer detection and workflow s
RadNet, Inc. announced its acquisition of iCAD, Inc. in a transaction valued at approximately $103 million, aimed at enhancing AI-powered breast cancer detection and diagnosis capabilities. The merger is expected to integrate iCAD’s ProFound Breast Health Suite into RadNet’s existing DeepHealth solutions. This strategic acquisition allows RadNet to expand its installed base of healthcare locations, bolstering its position in the cancer screening market. The deal is anticipated to close in the second or third quarter of 2025, subject to stockholder approval and customary conditions.
Read more →-RDNT
Mar 5, 2025RadNet Reports Fourth Quarter 2024 Results, Including Record Revenue and Adjusted EBITDA (1) and Releases 2025 Financial Guidance Total Company Revenue increased 13.5% to a quarterly record of $477.
RadNet reported strong financial results for the fourth quarter of 2024, achieving record revenue and Adjusted EBITDA. Total revenue increased by 13.5% to $477.1 million compared to the previous year, while the Digital Health segment saw a 28.1% rise in revenue. Despite the impressive growth, the company faced several one-time expenses that affected its net income. Dr. Howard Berger, CEO, highlighted ongoing demand and the successful launch of new technologies in the Digital Health division as key drivers of the company's performance.
Read more →-RDNT
Nov 22, 2024RadNet Secures Commitments to Amend its Credit Facility, resulting in 0.25% Reduction in Interest Rates
RadNet, Inc. has announced the successful completion of an amendment to its credit facility, which includes a reduction in interest rates by 0.25%. This reduction applies to both term loans totaling approximately $872.8 million and a revolving credit facility. The amendment is expected to save RadNet around $2.2 million in annual interest expenses. With a strong cash position and favorable leverage ratios, RadNet is in a solid position to pursue its business plan moving forward.
Read more →-RDNT
Nov 12, 2024RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA (1) and Revises Upwards 2024 Financial Guidance Ranges Total Company Revenue increased 14.7% to $461.
RadNet, Inc. reported robust financial results for Q3 2024, achieving a record revenue of $461.1 million, a 14.7% year-over-year increase. The company highlights significant growth in its Digital Health segment, particularly in AI-driven services, and has revised its 2024 financial guidance upwards due to strong demand. Despite some challenges, such as a net loss for the first nine months and higher staffing costs, RadNet's positive trends indicate a strong performance outlook. The company plans to expand its capacity by opening new imaging centers to meet increasing market demand.
Read more →-RDNT
Oct 10, 2024Jefferies Investor Update
RadNet provided an investor update highlighting their growth strategies and technological advancements in digital health. They aim to enhance their business through AI solutions and new software platforms like DeepHealth OS. While the company is expanding its services and capabilities, it also faces challenges such as radiologist shortages and operational inefficiencies. The update reinforces RadNet's commitment to innovation in radiology informatics as well as their focus on meeting the increasing demand in healthcare imaging.
Read more →-RDNT
Sep 12, 2024▲ +7.9%on this news
RadNet, Inc. Announces the Appointment of Kees Wesdorp as President and Chief Executive Officer of RadNet's Digital Health Division Former Chief Business Leader of Philips' multi-billion-dollar Prec
RadNet, Inc. has announced the appointment of Kees Wesdorp as President and CEO of its Digital Health division. Wesdorp brings extensive experience from his previous roles at Hellman & Friedman and Philips, where he oversaw large imaging divisions. His leadership is expected to strengthen RadNet's digital health offerings, particularly in AI applications and radiology informatics. The company aims to leverage his expertise to improve efficiency and patient outcomes in diagnostic imaging services.
Read more →-RDNT
Aug 9, 2024RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA (1) and Revises Upwards 2024 Financial Guidance Ranges Total Company Revenue increased 13.9% to $459
RadNet, Inc. reported strong financial results for the second quarter of 2024, achieving a record revenue of $459.7 million, up 13.9% from the previous year. The company also increased its Adjusted EBITDA to $72.3 million, a rise of 19.7%. Notably, the Digital Health segment saw a substantial revenue boost, primarily due to a 136.6% increase in AI revenue. In light of these positive trends, RadNet has revised its 2024 financial guidance upwards for revenue, Adjusted EBITDA, and Free Cash Flow.
Read more →-RDNT
May 8, 2024RadNet Reports First Quarter Financial Results with Record First Quarter Revenue, Adjusted EBITDA (1) and Adjusted Earnings (3) and Revises Upwards 2024 Financial Guidance Ranges Total Company Reven
RadNet, Inc. reported record first quarter results for 2024, with total revenue increasing by 10.5% to $431.7 million compared to the previous year. This growth was bolstered by a 32.3% rise in Digital Health revenue, particularly due to a 118.8% increase in AI revenue. The company also revised its financial guidance for 2024 upward, anticipating exceeding original revenue and EBITDA expectations. However, challenges such as severe winter weather and a continuing net loss were noted.
Read more →-RDNT
Apr 18, 2024RadNet Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction
RadNet, Inc. has successfully closed its refinancing of a senior secured first lien term loan and a senior secured revolving credit facility as part of a new Third Amended and Restated Credit Agreement. The refinancing involves a total of approximately $1.16 billion, which includes an $875 million term loan and a $282 million revolving credit facility. The company plans to utilize the proceeds to refinance existing debt and bolster its balance sheet, providing improved financial flexibility.
Read more →-RDNT
Apr 11, 2024RadNet Announces Pricing and Upsizing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction
RadNet has completed pricing for its refinancing plan, involving an upsized $875 million term loan and a $282 million revolving credit facility. This refinancing is aimed at reducing borrowing costs and boosting operational flexibility. The company plans to use a portion of the funds to repay existing debt and to enhance its balance sheet for future growth. The completion of the refinancing is expected in April 2024, pending final documentation and customary closing conditions.
Read more →-RDNT
Apr 3, 2024RadNet Announces a Proposed Refinancing of its Term Loan and Revolving Credit Facility
RadNet, Inc. announced a proposed refinancing of its existing term loan and revolving credit facility. The company plans to replace its current $679 million term loan and $195 million revolving credit facility with an $840 million term loan and a $250 million revolving credit line. Proceeds from this refinancing will not only repay existing debts but also bolster RadNet's cash reserves for growth opportunities. The finalization of this transaction depends on negotiations and market conditions, with expectations to complete it within the month.
Read more →-RDNT
Mar 7, 2024RADNET ANNOUNCES PROPOSED $200
RadNet, Inc. has announced its intention to conduct a $200 million public offering of common stock, with an additional option for underwriters to purchase up to $30 million more. The company plans to utilize the proceeds for general corporate purposes and potential acquisitions. The offering is subject to market conditions and is coordinated by Jefferies and Raymond James as the joint bookrunning managers. This could impact RadNet's business but also reflects its strong position in the outpatient diagnostic imaging industry.
Read more →-RDNT
Feb 29, 2024RadNet Reports Fourth Quarter 2023 Results, Including Record Revenue and Adjusted EBITDA (1) , Releases 2024 Financial Guidance and Forms a New Digital Health Reporting Segment Revenue increased 9.5
RadNet reported strong financial results for the fourth quarter of 2023, featuring record revenue of $420.4 million, a 9.5% increase from the previous year. Adjusted EBITDA also achieved a record of $68.3 million, reflecting an 11.0% growth. The company announced the establishment of a new Digital Health reporting segment and provided 2024 financial guidance indicating further growth in revenue and EBITDA. Despite a reported net loss, the impressive performance was driven by increased procedural volumes and significant growth in AI revenue.
Read more →-RDNT
Nov 8, 2023RadNet Reports Third Quarter Financial Results and Revises Upwards 2023 Financial Guidance Range for Adjusted EBITDA (1) Consolidated Revenue increased 14.8% to $402.0 million in the third quarter o
RadNet, Inc. reported a 14.8% increase in consolidated revenue for Q3 2023, reaching $402 million, alongside a 20.3% growth in Adjusted EBITDA. The positive performance is attributed to strong procedural volumes and a significant increase in their AI segment revenue, particularly from their new Enhanced Breast Cancer Detection service. The company has revised its 2023 financial guidance upwards as a result of its robust operational performance. However, it faces ongoing challenges due to a tight labor market and inflationary costs that could affect future expenses.
Read more →-RDNT
Aug 9, 2023RadNet Reports Second Quarter Financial Results, with Record Quarterly Revenue and Adjusted EBITDA (1) , and Updates 2023 Financial Guidance Ranges Revenue increased 13.9% to a quarterly record of $
RadNet, Inc. reported strong financial results for the second quarter of 2023, achieving record quarterly revenue of $403.7 million, a 13.9% increase compared to the previous year. The Adjusted EBITDA reached $60.4 million, marking a 17.7% growth. The company has revised its 2023 financial guidance upwards due to positive trends in their core imaging segment and significant growth in their AI division. However, losses from the AI reporting segment and delays in program rollout present challenges for future profitability.
Read more →-RDNT
May 11, 2023RadNet Reports First Quarter Financial Results with Record First Quarter Revenue and Adjusted EBITDA (1) from Imaging Center Operations and Revises Upwards 2023 Financial Guidance Ranges for Revenue
RadNet, Inc. reported strong financial results for the first quarter of 2023, achieving record revenue of $390.6 million and a significant increase in adjusted EBITDA. The company attributed these results to strong growth in procedural volumes despite the seasonally weak quarter. However, RadNet also faced challenges such as a net loss of $21 million and ongoing labor cost pressures. Given the positive trends, RadNet has revised its 2023 financial guidance upwards for both revenue and adjusted EBITDA.
Read more →-RDNT
Feb 28, 2023▲ +12%on this news
RadNet Reports Fourth Quarter 2022 Results, Including Record Revenue and Adjusted EBITDA (1) , and Releases 2023 Financial Guidance Revenue increased 15.2% to a record of $383.9 million in the fourt
RadNet, Inc. reported impressive financial results for the fourth quarter of 2022, achieving record revenue of $383.9 million, which marks a 15.2% year-over-year increase. The company also recorded an Adjusted EBITDA of $61.6 million, reflecting a strong performance in its Imaging Centers segment. For 2023, RadNet anticipates further growth across revenue, Adjusted EBITDA, and free cash flow, driven by high demand for diagnostic imaging services and strategic expansions. However, losses from its AI reporting segment remain a challenge, although the company expects these to narrow as it rolls out new services.
Read more →-RDNT
Nov 10, 2022▲ +6.6%on this news
C O R P O R A T E P A R T I C I P A N T S Mark Stolper, Executive Vice President and Chief Financial Officer Howard Berger, MD, President and Chief Executive Officer C O N F E R E N C E C A L L P A R T I C I P A N T S Br
C O R P O R A T E P A R T I C I P A N T S Mark Stolper, Executive Vice President and Chief Financial Officer Howard Berger, MD, President and Chief C O N F E R E N C E C A L L P A R T I C I P Brian Tanquilut, Jefferies Mitra Ramgopal, Sidoti & Company P R E S E N T A T I O
Read more →-RDNT
Nov 9, 2022▼ -11.2%on this newsshared move
RadNet Reports Third Quarter Financial Results and Revises 2022 Financial Guidance Ranges Revenue increased 5.2% to $350.0 million in the third quarter of 2022 from $332.7 million in the third quart
RadNet Reports Third Quarter Financial Results and Revises 2022 Financial Guidance Ranges Revenue increased 5.2% to $350.0 million in the third quarter of 2022 from $332.7 million in the third quarter of 2021; Excluding Revenue from our Artificial Intelligence ("AI") reportin
Read more →-RDNT
Aug 12, 2022C O R P O R A T E P A R T I C I P A N T S Mark Stolper, Executive Vice President and Chief Financial Officer Howard Berger, M.D., President and Chief Executive Officer C O N F E R E N C E C A L L P A R T I C I P A N T S
C O R P O R A T E P A R T I C I P A N T S Mark Stolper, Executive Vice President and Chief Financial Officer Howard Berger, M.D., President and Chief C O N F E R E N C E C A L L P A R T I C I P Brian Tanquilut, Jefferies Sarah James, Barclays Mitra Ramgopal, Sidoti & Co.
Read more →-RDNT
Aug 9, 2022▼ -5.7%on this newsshared move
RadNet Reports Second Quarter Financial Results and Reaffirms 2022 Financial Guidance Ranges Revenue increased 6.1% to $354.4 million in the second quarter of 2022 from $333.9 million in the second
Reports Second Quarter Financial Results and Reaffirms 2022 Financial Guidance Ranges LOS ANGELES, California, August 9, 2022 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a
Read more →-RDNT
May 9, 2022RadNet Reports First Quarter Financial Results with Record Revenue and Adjusted EBITDA (1) from Imaging Center Operations and Revises Upwards 2022 Financial Guidance Ranges Revenue increased 8.4% to
RadNet Reports First Quarter Financial Results with Record Revenue and Adjusted EBITDA(1) from Imaging Center Operations and Revises Upwards 2022 Financial Guidance Ranges LOS ANGELES, California, May 9, 2022 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-q
Read more →-RDNT
Mar 1, 2022▼ -7.1%on this news
RadNet Reports Fourth Quarter 2021 Results and Releases 2022 Financial Guidance Revenue increased 8.0% to $333.2 million in the fourth quarter of 2021 from $308.5 million in the fourth quarter of 20
RadNet Reports Fourth Quarter 2021 Results and Releases 2022 Financial LOS ANGELES, California, March 1, 2022 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 347
Read more →-RDNT
Jan 28, 2022C O R P O R A T E P A R T I C I P A N T S Mark Stolper, Executive Vice President and Chief Financial Officer Dr. Howard Berger, Co-Founder, Chairman, President and Chief Executive Officer Dr. Gregory Sorensen, Co-Founder
C O R P O R A T E P A R T I Mark Stolper, Executive Vice President and Chief Financial Officer Dr. Howard Berger, Co-Founder, Chairman, President and Chief Executive Officer Dr. Gregory Sorensen, Co-Founder and Chief Executive Officer, DeepHealth, and President AI Division,
Read more →-RDNT
Jan 24, 2022RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial Intelligence When combined wit
RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial Intelligence When combined with RadNet's existing DeepHealth mammography AI division, the two acquisitions p
Read more →-RDNT
Nov 8, 2021RadNet Reports Third Quarter Financial Results and Revises Upward 2021 Financial Guidance Ranges for Adjusted EBITDA (1) and Free Cash Flow (2) Revenue increased 14.0% to $332.7 million in the third
RadNet Reports Third Quarter Financial Results and Revises Upward 2021 Financial Guidance Ranges for Adjusted EBITDA(1) and Free Cash Flow(2) Revenue increased 14.0% to $332.7 million in the third quarter of 2021 from $291.8 million in the third quarter of 2020 Adjusted EBI
Read more →-RDNT
Aug 9, 2021▼ -8.3%on this news
Revenue increased 75.2% to an all-time quarterly record of $333.9 million in the second quarter of 2021 from $190.6 million in the second quarter of 2020 Adjusted EBITDA (1) increased 150.7% to an a
LOS ANGELES, California, August 9, 2021 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 353 owned and/or operated outpatient imaging centers, today reported financ
Read more →-RDNT
May 10, 2021RadNet Reports First Quarter Financial Results, Including Record First Quarter Revenue, Adjusted EBITDA (1) and Net Income, and Revises Upwards 2021 Financial Guidance Ranges Revenue increased 12.0%
RadNet Reports First Quarter Financial Results, Including Record First Quarter Revenue, Adjusted EBITDA(1) and Net Income, and Revises Upwards 2021 Financial LOS ANGELES, California, May 10, 2021 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-
Read more →-RDNT
Apr 26, 2021RadNet Announces the Closing of Its Previously Announced Refinancing Transaction
RadNet Announces the Closing of Its Previously Announced Refinancing LOS ANGELES, April 26, 2021 (GLOBE NEWSWIRE) - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and/or operated o
Read more →-RDNT
Apr 6, 2021RadNet Announces a Proposed Refinancing Transaction for its $611 Million Senior Secured Term Loan and $195 Million Senior Secured Revolving Credit Facility
RadNet Announces a Proposed Refinancing Transaction for its $611 Million Senior Secured Term Loan and $195 Million Senior Secured Revolving Credit Facility LOS ANGELES, April 06, 2021 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality,
Read more →-RDNT
Mar 8, 2021RadNet Reports Fourth Quarter Results with Record Revenue and Adjusted EBITDA and Releases 2021 Financial Guidance Despite the ongoing impact of COVID-19, RadNet reports record fourth quarter 2020 T
RadNet Reports Fourth Quarter Results with Record Revenue and Adjusted EBITDA and Releases 2021 Financial Guidance LOS ANGELES, California, March 8, 2021 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnosti
Read more →-RDNT
Nov 9, 2020RadNet Reports Third Quarter Financial Results Demonstrating Strong Recovery from the COVID-19 Impact Indicating a substantial recovery from the impact of COVID-19, Total Net Revenue ("Revenue") was
RadNet Reports Third Quarter Financial Results Demonstrating Strong Recovery from the COVID-19 Impact LOS ANGELES, California, November 9, 2020 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging
Read more →-RDNT
Aug 31, 2020RadNet Expands its Revolving Credit Facility to $195 million
RadNet Expands its Revolving Credit Facility to $195 million LOS ANGELES, California, August 31, 2020 (GLOBE NEWSWIRE) - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netwo
Read more →-RDNT
Aug 10, 2020RadNet Reports Second Quarter Financial Results As a result of taking immediate expense and cash savings measures to react to the impact of COVID-19 on patient volume, RadNet finished the quarter wi
RadNet Reports Second Quarter LOS ANGELES, California, August 10, 2020 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 332 owned and/or operated outpatient imagin
Read more →-RDNT
May 11, 2020RadNet Reports First Quarter Financial Results and Announces Strong Liquidity Position as a Result of Completing Cost Savings and Cash Conservation Measures Liquidity and Business Update: RadNet has
RadNet Reports First Quarter Financial Results and Announces Strong Liquidity Position as a Result of Completing Cost Savings and Cash Conservation Measures Liquidity and Business Update: LOS ANGELES, California, May 11, 2020 - RadNet, Inc. (NASDAQ: RDNT), a national leader i
Read more →-RDNT
Mar 13, 2020C O R P O R A T E P A R T I C I P A N T S Dr. Howard G. Berger, President and Chief Executive Officer, RadNet Inc. Dr. Gregory Sorensen, Chief Executive Officer and Co-Founder, DeepHealth Inc. C O N F E R E N C E C A L L
R A T E P A R T I C I P A N T S Dr. Howard G. Berger, President and Chief Executive Officer, RadNet Inc. Sorensen, Chief Executive Officer and Co-Founder, DeepHealth Inc. R E N C E C A L L P A R T I C I P A N T S Mitra Ramgopal, Sidoti & Good day everyone. Welcome to the Ra
Read more →-RDNT
Mar 12, 2020RadNet Reports Record Fourth Quarter and Full Year 2019 Results and Releases 2020 Financial Guidance For the fourth quarter of 2019, RadNet reports Total Net Revenue ("Revenue") of $300.8 million an
RadNet Reports Record Fourth Quarter and Full Year 2019 Results and Releases 2020 Financial Guidance LOS ANGELES, California, March 12, 2020 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging se
Read more →-RDNT
Nov 12, 2019RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2019 Guidance Levels Total Net Revenue ("Revenue") increased 20.9% to $292.7 million in the third quarter of 2019 fr
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2019 Guidance Levels LOS ANGELES, California, November 12, 2019 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imagi
Read more →-RDNT
Aug 8, 2019RadNet Reports Second Quarter Financial Results and Increases Financial Guidance Levels Revenue increased 18.3% to $----289.1 million in the second quarter of 2019 from $244.4 million in the second
RadNet Reports Second Quarter Financial Results and Increases Financial Guidance Levels LOS ANGELES, California, August 8, 2019 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services throug
Read more →-RDNT
May 9, 2019RadNet Reports First Quarter Financial Results, Including Record Revenue and Adjusted EBITDA (1) Revenue increased 17.4% to $271.5 million in the first quarter of 2019 from $231.4 million in the fir
RadNet Reports First Quarter Financial Results, Including Record Revenue and Adjusted EBITDA(1) LOS ANGELES, California, May 9, 2019 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services t
Read more →-RDNT
Mar 14, 2019RadNet Reports Record Fourth Quarter and Full Year 2018 Results and Releases 2019 Financial Guidance For the fourth quarter of 2018, RadNet reports Total Net Revenue ("Revenue") of $257.2 million an
RadNet Reports Record Fourth Quarter and Full Year 2018 Results and Releases 2019 Financial Guidance LOS ANGELES, California, March 14, 2019 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging se
Read more →-RDNT
Nov 9, 2018RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2018 Guidance Levels Total Net Revenue ("Revenue") increased 6.4% to $242.1 million in the third quarter of 2018 fro
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2018 Guidance Levels LOS ANGELES, California, November 9, 2018 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imagin
Read more →-RDNT
Aug 9, 2018RadNet Reports Second Quarter Financial Results to Include Record Revenue and Reaffirms Guidance Ranges Total Net Revenue increased 6.3% to $244.4 million in the second quarter of 2018 from $230.0 m
RadNet Reports Second Quarter Financial Results to Include Record Revenue and Reaffirms Guidance Ranges LOS ANGELES, California, August 9, 2018 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging
Read more →-RDNT
May 9, 2018RadNet Reports First Quarter Financial Results Severe weather in the Northeast impacted Total Net Revenue ("Revenue") by an estimated $5.9 million and Adjusted EBITDA (1) by $5.8 million in the firs
RadNet Reports First Quarter Financial Results LOS ANGELES, California, May 9, 2018 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 300 owned and/or operated outp
Read more →-RDNT
Mar 8, 2018RadNet Reports Record Fourth Quarter and Full Year 2017 Results and Releases 2018 Financial Guidance For the fourth quarter of 2017, RadNet reports record Total Net Revenue ("Revenue")
RadNet Reports Record Fourth Quarter and Full Year 2017 Results and Releases 2018 Financial Guidance LOS ANGELES, California, March 8, 2018 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging ser
Read more →-RDNT
Nov 9, 2017RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels Total Net Revenue ("Revenue") increased 1.3% to $227.6 million in the third quarter of 2017 fro
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels LOS ANGELES, California, November 9, 2017 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imagin
Read more →-RDNT
Aug 22, 2017RadNet Announces the Completion of an Amendment to its First Lien Credit Facilities and the Retirement of its Second Lien Term Loan
RadNet Announces the Completion of an Amendment to its First Lien Credit Facilities and the Retirement of its Second Lien Term Loan LOS ANGELES, California, August 22, 2017 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, fixed-site outpatient diagno
Read more →-RDNT
Aug 8, 2017RadNet Reports Second Quarter Financial Results to Include Record Revenue and EBITDA, the Acquisition of Diagnostic Imaging Associates of Delaware and a Refinancing Transaction RadNet reports record
RadNet Reports Second Quarter Financial Results to Include Record Revenue and EBITDA, the Acquisition of Diagnostic Imaging Associates of Delaware and a Refinancing Transaction LOS ANGELES, California, August 8, 2017 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providin
Read more →-RDNT
Jun 13, 2017RADNET, INC. 2006 EQUITY INCENTIVE PLAN (Amended and Restated as of
2006 EQUITY INCENTIVE PLAN (Amended and Restated as of March 9, Purpose of the Plan. The purpose of this Plan is to encourage ownership in the Company by key personnel whose long-term service the Company considers essential to its continued progress and, thereby, encourage rec
Read more →-RDNT
May 10, 2017RadNet Reports First Quarter Financial Results and Reaffirms 2017 Guidance Ranges Total Net Revenue ("Revenue") increased 5.8% to $229.0 million in the first quarter of 2017 from $216.4 million in t
RadNet Reports First Quarter Financial Results and Reaffirms 2017 Guidance Ranges LOS ANGELES, California, May 10, 2017 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw
Read more →-RDNT
Mar 14, 2017RadNet Reports Record Fourth Quarter and Full Year 2016 Results and Releases 2017 Financial Guidance For the fourth quarter, RadNet reports record Total Net Revenue ("Revenue") of $224.9 million, an
RadNet Reports Record Fourth Quarter and Full Year 2016 Results and Releases 2017 Financial Guidance LOS ANGELES, California, March 14, 2017 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging se
Read more →-RDNT
Feb 2, 2017RadNet Announces Amendment to First Lien Credit Facilities
RadNet Announces Amendment to First Lien Credit Facilities LOS ANGELES, California, February 2, 2017 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a network of 306 owned and/or operated out
Read more →-RDNT
Nov 9, 2016RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2016 Guidance Levels Total Net Revenue increased 7.8% to $224.6 million in the third quarter of 2016 from $208.4 mil
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2016 Guidance Levels LOS ANGELES, California, November 9, 2016 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imagin
Read more →-RDNT
Aug 9, 2016RadNet Reports Second Quarter Financial Results and Reaffirms Previously Announced 2016 Guidance Levels Total Net Revenue, modified for working capital adjustments related to New York acquisitions,
RadNet Reports Second Quarter Financial Results and Reaffirms Previously Announced 2016 Guidance Levels California, August 9, 2016 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services thro
Read more →-RDNT
Jul 1, 2016RadNet Announces the Closing of Amended and Restated $602.5 Million First Lien Credit Facilities
RadNet Announces the Closing of Amended and Restated $602.5 Million First Lien Credit Facilities LOS ANGELES, California, July 1, 2016 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a netwo
Read more →-RDNT
Jun 2, 2016RadNet Announces a Proposed Refinancing of its $444.8 Million Senior Secured First Lien Term Loans and $101.25 Million Senior Secured Revolving Credit Facility
RadNet Announces a Proposed Refinancing of its $444.8 Million Senior Secured First Lien Term Loans and $101.25 Million Senior Secured Revolving Credit Facility LOS ANGELES, California, June 2, 2016 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cos
Read more →-RDNT
May 10, 2016RadNet Reports First Quarter Financial Results, Announces its First Health System Joint Venture in California and Reaffirms 2016 Guidance Ranges Total Net Revenue ("Revenue") increased 19.4% to $216
RadNet Reports First Quarter Financial Results, Announces its First Health System Joint Venture in California and Reaffirms 2016 Guidance Ranges California, May 10, 2016 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outp
Read more →-RDNT
Mar 14, 2016RadNet Reports Fourth Quarter and Full Year 2015 Results and Releases 2016 Financial Guidance For the fourth quarter, RadNet reports Total Net Revenue ("Revenue") of $215.7 million and Adjusted EBIT
RadNet Reports Fourth Quarter and Full Year 2015 Results and Releases 2016 Financial Guidance California, March 14, 2016 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw
Read more →-RDNT
Nov 9, 2015RadNet Reports Third Quarter Financial Results Total Net Revenue ("Revenue") increased 13.2% to $208.4 million in the third quarter of 2015 from $184.1 million in the third quarter of 2014 Adjusted
RadNet Reports Third Quarter Financial California, November 9, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 297 owned and/or operated outpatient imaging c
Read more →-RDNT
Oct 16, 2015RadNet Expands Its New York City Metropolitan Area Presence Through the Acquisition of Diagnostic Imaging Group
Its New York City Metropolitan Area Presence Through the Acquisition of Diagnostic Imaging Group, LLC Oct. 16, 2015 (GLOBE NEWSWIRE) - RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services toda
Read more →-RDNT
Aug 10, 2015RadNet Reports Second Quarter Financial Results and Reaffirms Previously Announced 2015 Guidance Levels Total Net Revenue ("Revenue") increased 14.1% to $204.3 million in the second quarter of 2015
RadNet Reports Second Quarter Financial Results and Reaffirms Previously Announced 2015 Guidance Levels California, August 10, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services thr
Read more →-RDNT
May 11, 2015RadNet Reports First Quarter Financial Results and Adjusts Upwards 2015 Guidance Ranges Despite more severe weather conditions in the east coast this quarter as compared with last year's first quart
RadNet Reports First Quarter Financial Results and Adjusts Upwards 2015 Guidance Ranges California, May 11, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 2
Read more →-RDNT
Apr 30, 2015RadNet Secures Additional $75 Million as Part of its Existing Senior Secured Credit Facility
RadNet Secures Additional $75 Million as Part of its Existing Senior Secured Credit Facility California, April 30, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netwo
Read more →-RDNT
Mar 16, 2015RadNet Reports Fourth Quarter and Record Full Year 2014 Results and Releases 2015 Financial Guidance For the fourth quarter, RadNet reports Total Net Revenue ("Revenue") of $185.6 million and Adjust
RadNet Reports Fourth Quarter and Record Full Year 2014 Results and Releases 2015 Financial Guidance California, March 16, 2015 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through
Read more →-RDNT
Nov 6, 2014Press Release dated
RadNet Reports Record Third Quarter Financial Results and Adjusts Upwards 2014 Guidance Ranges for Revenue and Adjusted EBITDA(1) California, November 6, 2014 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diag
Read more →-RDNT
Aug 8, 201499.1 Press Release dated
Release dated August 8, 2014 RadNet Reports Record Second Quarter Financial Results and Adjusts Upwards 2014 Guidance Ranges for Revenue and Adjusted EBITDA(1) California, August 8, 2014 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective
Read more →-RDNT
Apr 25, 2014RadNet Announces Redemption of Remaining 10 3/8% Senior Notes and Satisfaction and Discharge of Indenture
RadNet Announces Redemption of Remaining 10 3/8% Senior Notes and Satisfaction and Discharge of Indenture LOS ANGELES, April 25, 2014 (GLOBE NEWSWIRE) - Radnet Management, Inc. ("Radnet Management") and its parent, RadNet, Inc. (Nasdaq: RDNT) (the "Company"), a national leade
Read more →-RDNT
Apr 4, 2014RadNet Announces Expiration of Its Tender Offer and Consent Solicitation for its 10 3/8% Senior Notes due 2018
RadNet Announces Expiration of Its Tender Offer and Consent Solicitation for its 10 3/8% Senior Notes due 2018 LOS ANGELES, April 4, 2014 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq: RDNT) (the "Company"), a national leader in providing high-quality, cost-effective, fixed-site o
Read more →-RDNT
Mar 25, 2014SECOND AMENDMENT AGREEMENT dated as of
SECOND AMENDMENT AGREEMENT dated as of March 25, 2014 (this "Second Amendment"), to the Credit Agreement referred to below is by and among RADNET MANAGEMENT, INC., a California corporation (the "Borrower"), RADNET, INC., a Delaware corporation ("Holdings"), CERTAIN SUBSIDIARIE
Read more →-RDNT
Mar 25, 2014RadNet Announces Completion of its Previously Announced Senior Debt Refinancing and Receipt of Required Consents for its Previously Announced Tender Offer and Consent Solicitation for its 10 3/8% Se
RadNet Announces Completion of its Previously Announced Senior Debt Refinancing and Receipt of Required Consents for its Previously Announced Tender Offer and Consent Solicitation for its 10 3/8% Senior Notes due 2018 LOS ANGELES, March 25, 2014 (GLOBE NEWSWIRE) -- RadNet, Inc
Read more →-RDNT
Mar 7, 2014RadNet Commences Tender Offer and Consent Solicitation for 10 3/8% Senior Notes due 2018
RadNet Commences Tender Offer and Consent Solicitation for 10 3/8% Senior Notes due 2018 LOS ANGELES, California, March 7, 2014 - RadNet, Inc. (NASDAQ: RDNT) (the "Company") announced today that it has commenced a tender offer to purchase for cash any and all of the outstandi
Read more →-RDNT
Mar 6, 2014RadNet Proposed Refinancing Transaction
RadNet Proposed Refinancing Transaction LOS ANGELES, March 6, 2014 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq: RNDT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 250 owned and/or operated out
Read more →-RDNT
Mar 3, 2014RadNet Reports Fourth Quarter and Full Year 2013 Results, Releases 2014 Financial Guidance and Announces a Proposed Refinancing Transaction of its $200 million 10 3/8% Senior Unsecured Notes For the
RadNet Reports Fourth Quarter and Full Year 2013 Results, Releases 2014 Financial Guidance and Announces a Proposed Refinancing Transaction of its $200 million 10 3/8% Senior Unsecured Notes For the fourth quarter, RadNet reports Total Net Revenue ("Revenue") of $178.3 milli
Read more →-RDNT
May 10, 2013RadNet Reports First Quarter Financial Results and Reaffirms 2013 Full-Year Guidance Service Fee Revenue, net of contractual allowances and discounts ("Revenue") was $179.8 million, an increase of 6
RadNet Reports First Quarter Financial Results and Reaffirms 2013 Full-Year Guidance California, May 10, 2013 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 248
Read more →-RDNT
Apr 3, 2013FIRST AMENDMENT AGREEMENT dated as of
FIRST AMENDMENT AGREEMENT dated as of April 3, 2013 (this "First Amendment"), to the Credit and Guaranty Agreement dated as of October 10, 2012 (as amended, supplemented or otherwise modified prior to the date hereof, the "Credit Agreement"), by and among RADNET MANAGEMENT, IN
Read more →-RDNT
Mar 20, 2013, issued by RadNet, Inc. on
Announces its Intention to Re-Price its Senior Secured Term Loan and Raise an Additional $40 Million LOS ANGELES, California, March 20, 2013 -RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging serv
Read more →-RDNT
Jan 2, 2013RadNet Enters the New York City Marketplace through the Acquisition of Lenox Hill Radiology
RadNet Enters the New York City Marketplace through the Acquisition of Lenox Hill Radiology California, January 2, 2013 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netwo
Read more →-RDNT
Oct 10, 2012CREDIT AND GUARANTY AGREEMENT dated as of
CREDIT AND GUARANTY AGREEMENT dated as of October 10, 2012 RADNET MANAGEMENT, INC., CERTAIN SUBSIDIARIES AND AFFILIATES OF RADNET MANAGEMENT, INC., The Several Lenders from Time to Time GE CAPITAL MARKETS, INC., RBC CAPITAL MARKETS, DEUTSCHE BANK SECURITIES INC., as Join
Read more →-RDNT
Sep 18, 2012RadNet Launches a Refinancing of Its Senior Credit Facilities
RadNet Launches a Refinancing of Its Senior Credit Facilities LOS ANGELES, Sept. 18, 2012 (GLOBE NEWSWIRE) -- RadNet, Inc. (Nasdaq: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 237 o
Read more →-RDNT
Mar 8, 2012RadNet Reports Record Full Year 2011 and Fourth Quarter Results and Releases 2012 Financial Guidance For the year, RadNet reports record annual Revenue of $619.8 million and record ann
RadNet Reports Record Full Year 2011 and Fourth Quarter Results and Releases 2012 Financial Guidance LOS ANGELES, California., March 8, 2012 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging servi
Read more →-RDNT
Nov 9, 2011RadNet Reports Quarterly Financial Results and Reaffirms 2011 Full-Year Guidance Revenue was $150.8 million, an increase of 7.7% from $140.1 million in the third quarter of 2010 Adjusted EBITDA (1)
RadNet Reports Quarterly Financial Results and Reaffirms 2011 Full-Year Guidance Revenue was $150.8 million, an increase of 7.7% from $140.1 million in the third quarter of 2010 Adjusted EBITDA (1) was $27.0 million, a decrease of 3.7% from $28.0 million in the prior year's
Read more →-RDNT
Nov 8, 201199.1 FOR IMMEDIATE RELEASE RadNet Acquires the United States Imaging Operations of CML HealthCare and Increases the Size of Its Current Revolving Credit Facility
RadNet Acquires the United States Imaging Operations of CML HealthCare and Increases the Size of Its Current Revolving Credit Facility LOS ANGELES, California, November 8, 2011 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site
Read more →-RDNT
May 10, 2011RadNet Reports First Quarter Financial Results and Reaffirms 2011 Full-Year Guidance Revenue was $146.2 million, an increase of 17.7% from $124.2 million in the first quarter of 2010 Adjusted EBITDA
RadNet Reports First Quarter Financial Results and Reaffirms 2011 Full-Year Guidance LOS ANGELES, California, May 10, 2011 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a netw
Read more →-RDNT
Apr 8, 2011RadNet Completes the Previously Announced Acquisition of Imaging Centers in Maryland from Diagnostic Health Corporation
RadNet Completes the Previously Announced Acquisition of Imaging Centers in Maryland from Diagnostic Health Corporation LOS ANGELES, California, April 8, 2011 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagno
Read more →-RDNT
Mar 9, 2011RadNet Reports Record 2010 Fourth Quarter Results and Releases 2011 Financial Guidance For the fourth quarter, RadNet reports record Revenue of $145.3 million and record Adjusted EBITD
RadNet Reports Record 2010 Fourth Quarter Results and Releases 2011 Financial Guidance LOS ANGELES, California., March 8, 2011 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a
Read more →-RDNT
Mar 7, 2011RadNet to Acquire Imaging Centers in Maryland from Diagnostic Health Corporation
RadNet to Acquire Imaging Centers in Maryland from Diagnostic Health Corporation LOS ANGELES, California, March 7, 2011 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network
Read more →-RDNT
Jan 4, 2011RadNet Completes the Previously Announced Acquisition of Imaging On Call
RadNet Completes the Previously Announced Acquisition of Imaging On Call LOS ANGELES, Calif., January 4, 2011 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 198 fu
Read more →-RDNT
Dec 22, 2010RadNet to Enter the Teleradiology and Remote Interpretation Business through the Acquisition of Imaging On Call
RadNet to Enter the Teleradiology and Remote Interpretation Business through the Acquisition of Imaging On Call LOS ANGELES, California, December 22, 2010 - RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic
Read more →Competitive Position
How RDNT ranks across every disease it competes inCompetitive Position is a premium feature
See how RDNT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial